Most people on GLP-1 drugs can safely fast for Yom Kippur or other religious observances, but they may need to plan ahead, take certain precautions or be ready to call it quits if they feel ill.
Articles on Mounjaro
Displaying 1 - 20 of 34 articles
GLP-1 drugs can produce major weight loss, but their wider impact will depend on affordable treatment and appropriate support.
GLP-1 disclosure in dating is fraught and inconsistent largely due to the stigma around losing weight the “right way.”
Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who are healthier, wealthier and with better access to care.
Many people regain weight after stopping GLP-1 medicines. Long-term support may be as important as the drugs themselves.
New data shows obesity rising fastest among the young and the poor, while it’s mainly the better off who are seeing the benefit of weight-loss drugs.
Orforglipron could help keep the weight off after people come off the expensive weight-loss jabs.
The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.
GLP-1 drugs are the first medication to show promise for treating addiction to a wide range of substances.
Appetite is governed by gut hormones, not willpower. GLP-1 therapies extend natural satiety signals and expose the biology behind eating.
As GLP-1 medications surge in popularity, companies are selling tailored supplements. Science suggests most people do not need them.
Due to the body’s natural tendency to restore its former weight, many people regain their lost weight when they stop using GLP-1 drugs.
New weight loss jabs work brilliantly – but only while you’re taking them. The rebound is fast, and the cost-effectiveness unclear.
Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in those taking Ozempic, Wegovy and Mounjaro.
Are weight loss shots like Ozempic and Wegovy safe long-term? It’s complicated. Some early studies suggest thyroid concerns while others hint at cancer prevention.
The development of new weight loss drugs is one way that patient access can be ensured in the future.
Mounjaro offers up to 20% weight loss – but it’s not for everyone. Learn about eligibility, alternatives and why long-term habits still matter most.
Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.
Mounjaro leads to weight loss, which can help patients with sleep apnoea.
Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health conditions.
Top contributors
-
Associate Professor of Physiology and Medical Education, Anglia Ruskin University
-
Clinical Epidemiologist, Washington University in St. Louis
-
Associate Professor in Pharmacy Practice, University of Bradford
-
Research Lead/Advanced Clinical Practitioner/Senior Research Fellow, University of Bradford
-
Professor of Health Service Operations, School of Pharmacy & Medical Sciences, University of Bradford
-
Professor of Physiology, Kavli Institute for Fundamental Neuroscience, University of California, San Francisco
-
Professor of Law, Villanova University
-
Postdoctoral Research Fellow, Edge Hill University
-
Professor of Exercise Science and Interim Dean of the School of Health Sciences, College of Charleston
-
Professor of Diet and Population Health, University of Oxford
-
Senior Lecturer, Pharmacy, Aston University
-
Clinical Associate Professor, Diabetes and Endocrinology, Aston University
-
Honorary Associate Professor, University of Leicester
-
Associate Professor of Metabolic Medicine, University of Surrey
-
Associate Professor, School of Health Studies, Western University